Myopia Medical Services in China

Myopia, or nearsightedness, is a common refractive error in which distant objects appear blurry while close objects remain clear. It occurs when the eyeball is too long or the cornea’s curvature is too steep, causing light to focus in front of—not directly on—the retina. Prevalence is rising globally, especially among children and adolescents, with estimates suggesting over 30% of the world’s population affected—reaching up to 80–90% in some East Asian countries. While mild myopia can be corrected with glasses or contact lenses, progressive cases may lead to serious complications such as retinal detachment, glaucoma, or myopic maculopathy later in life. Early detection, lifestyle interventions (e.g., increased outdoor time), and evidence-based treatments—including orthokeratology (Ortho-K), low-dose atropine eye drops, and specialized multifocal contact lenses—are critical for slowing progression, particularly in pediatric patients. Surgical options like SMILE, LASIK, and ICL implantation are highly effective for stable adult myopia but require careful patient selection and thorough preoperative evaluation.

China offers distinct advantages for myopia management: world-class ophthalmic centers equipped with cutting-edge diagnostic tools (e.g., axial length biometry, wide-field retinal imaging), standardized national screening programs integrated into school health systems, and rapidly advancing research in myopia control—especially in pharmacologic and optical interventions. Chinese ophthalmologists have pioneered large-scale longitudinal studies demonstrating up to 60% reduction in annual axial elongation using combination therapies. Leading institutions such as Zhongshan Ophthalmic Center (Sun Yat-sen University) and Shanghai Eye & ENT Hospital report >95% patient satisfaction rates and publish regularly in top-tier journals including *Ophthalmology* and *JAMA Ophthalmology*.

Treatment Options & Itemized Cost Breakdown for Myopia

Non-Surgical / Conservative Management

Target Criteria: Children <12 years (progression control), adults with ≤−6.00 D refractive error, contraindications to surgery, or preference for non-invasive care.

• •Comprehensive Refractive Exam + Axial Length Measurement: $45–$65
• •Orthokeratology (OK) Lens Fitting & 6-Month Follow-up Package:

- Initial fitting & training: $320

- Custom OK lenses (1 pair, 1-year lifespan): $780 - Quarterly monitoring (4 visits/year): $240

• •Low-Dose Atropine (0.01%) Therapy (1-year supply + monitoring):

- Prescription + compounding fee: $95

- Biannual cycloplegic refraction & IOP check: $130

• •Behavioral Intervention Program (digital screen time management, outdoor activity coaching): $180 (one-time, includes 3 sessions + app access)

Surgical / Procedural Interventions

Eligibility Criteria: Age ≥18 years, stable refraction (≤0.50 D change in past 2 years), corneal thickness ≥480 µm, no active keratoconus or severe dry eye.

• •Preoperative Workup (mandatory for all procedures): $210

*(Includes topography, pachymetry, wavefront aberrometry, tear film assessment, and dilated fundus exam)*

• •SMILE (Small Incision Lenticule Extraction):

- Standard SMILE (−1.00 to −10.00 D): $2,450–$3,100

- SMILE with enhanced centration algorithm (for astigmatism >2.00 D): $3,350

• •FS-LASIK (Femtosecond Laser-Assisted In Situ Keratomileusis):

- Standard FS-LASIK: $2,200–$2,750

- Wavefront-Guided FS-LASIK: $3,050

• •ICL (Implantable Collamer Lens) – Posterior Chamber Implant:

- Toric ICL (for ≥1.50 D cylinder): $5,900–$6,400

- Non-toric ICL: $5,200

Special/Complex Condition Management

• •Progressive Myopia in Children (<12 years) with ≥1.00 D/year progression:

- Combined therapy (0.01% atropine + OK lenses + outdoor activity prescription): $1,280/year

• •High Myopia (≥−8.00 D) with posterior staphyloma or lattice degeneration:

- Annual structural OCT + widefield fundus imaging + specialist consultation: $390

• •Myopia-Related Glaucoma Suspect (elevated IOP + optic nerve asymmetry):

- 24-hour IOP curve + visual field testing + GDx RNFL scan: $470

Quick Selection Guide

• •Children aged 6–12, rapid progression (>0.75 D/year): Start with 0.01% atropine + OK lenses ($1,280/year) — highest evidence for slowing axial elongation.
• •Adults 18–40, −3.00 to −6.00 D, stable refraction, budget <$3,000: FS-LASIK ($2,200–$2,750) offers fastest visual recovery and lowest complication risk.
• •Adults ≥40, −6.00 to −10.00 D, thin cornea or dry eye: SMILE ($2,450–$3,100) preserves corneal biomechanics better than LASIK.
• •Patients ≥−10.00 D or corneal thickness <480 µm: ICL implantation ($5,200–$6,400) is the only viable surgical option.
• •Elderly patients (>60 years) with cataract co-morbidity: Cataract extraction with toric/EDOF IOL ($3,800–$4,600) corrects myopia *and* lens opacity simultaneously.